MaxCyte (MXCT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
MaxCyte, Inc. has announced a change in major holdings as BlackRock, Inc. now holds 8.52% of the company’s voting rights, following a recent acquisition. This development is significant for investors tracking major moves in the biotech sector, as it may influence MaxCyte’s strategic decisions and market performance.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
